Company intelligence / Profile preview

ViOptix

Newark, California, United Statesvioptix.com ↗

Ownership: Private
Employees: ~75
Development stage: Other

Overview

ViOptix has developed and commercialized FDA-cleared non-invasive devices that provide real-time measurement of local tissue oxygen saturation using near-infrared spectroscopy. Their products are widely adopted as standard of care in leading hospitals for surgical and critical care applications. Numerous clinical studies support their efficacy, particularly in reconstructive microsurgery to detect compromised blood flow before clinical symptoms arise.

Therapeutic areas: DermatologyCardiovascularOncologyOther
Modalities: DeviceDiagnostic deviceMonitoring device (non-invasive)
Industry: Physiological Monitoring

Beyond the preview

Go deeper on ViOptix.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ViOptix.

Explore the full profile